Yu Jiang Selected Research

Lymphoma (Lymphomas)

9/2021	Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
7/2017	A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.
10/2016	Aidi injection combined with CHOP chemotherapy regimen in the treatment of malignant lymphoma: A meta-analysis based on randomized controlled trials.
1/2016	Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
7/2013	Measurement of distress in Chinese inpatients with lymphoma.
2/2013	Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.
1/2013	Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.
7/2012	Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
9/2008	Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Jiang Research Topics

Disease

129	Neoplasms (Cancer) 04/2022 - 02/2002
25	Inflammation (Inflammations) 03/2022 - 02/2010
16	Infections 05/2022 - 02/2005
16	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2004
15	Neoplasm Metastasis (Metastasis) 04/2021 - 05/2009
14	Sepsis (Septicemia) 01/2022 - 01/2015
12	Hemorrhage 05/2020 - 01/2002
11	Insulin Resistance 06/2022 - 02/2007
11	Breast Neoplasms (Breast Cancer) 04/2022 - 05/2010
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2006
10	Osteoporosis 10/2022 - 01/2016
10	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2017
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2015
9	Lymphoma (Lymphomas) 09/2021 - 09/2008
8	Non-alcoholic Fatty Liver Disease 02/2022 - 10/2017
8	Reperfusion Injury 01/2022 - 01/2015
8	Fibrosis (Cirrhosis) 01/2022 - 01/2017
7	Pain (Aches) 01/2022 - 10/2008
7	Diarrhea 01/2022 - 01/2016
7	Body Weight (Weight, Body) 01/2022 - 04/2010
7	Carcinogenesis 04/2021 - 01/2017
7	Nasopharyngeal Carcinoma 01/2021 - 01/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2006
7	Stroke (Strokes) 01/2021 - 01/2018
7	Hypertension (High Blood Pressure) 01/2020 - 02/2014
6	Type 2 Diabetes Mellitus (MODY) 06/2022 - 09/2011
6	Myocardial Infarction 06/2022 - 02/2019
6	Ischemia 06/2022 - 01/2018
6	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 01/2018
6	Adenocarcinoma 01/2022 - 06/2006
6	Obesity 01/2022 - 05/2013
6	Carcinoma (Carcinomatosis) 01/2022 - 09/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 02/2010
6	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2017
6	Liver Diseases (Liver Disease) 10/2020 - 07/2017
6	Glioma (Gliomas) 01/2020 - 08/2011
5	Ischemic Stroke 06/2022 - 04/2020
5	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2021
5	Disease Progression 01/2022 - 11/2011
5	COVID-19 01/2022 - 01/2020
5	Lung Injury 01/2022 - 05/2015
5	Hypoxia (Hypoxemia) 01/2022 - 10/2015
5	Weight Loss (Weight Reduction) 11/2021 - 09/2007
5	Cognitive Dysfunction 01/2021 - 01/2018
5	Birth Weight (Birth Weights) 01/2021 - 08/2017
5	Wounds and Injuries (Trauma) 07/2020 - 03/2005
5	Colonic Neoplasms (Colon Cancer) 12/2017 - 06/2005
4	Hyperuricemia 07/2022 - 12/2020
4	Substance-Related Disorders (Drug Abuse) 01/2022 - 03/2013

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2003
30	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2013
28	Pharmaceutical PreparationsIBA 01/2022 - 05/2010
15	Biological ProductsIBA 01/2022 - 05/2004
14	Mechanistic Target of Rapamycin Complex 1IBA 09/2021 - 12/2006
13	Messenger RNA (mRNA)IBA 01/2022 - 08/2005
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2007
9	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2016
9	CytokinesIBA 01/2022 - 10/2015
9	AntigensIBA 03/2021 - 02/2002
9	VaccinesIBA 01/2020 - 02/2002
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2014
8	LipidsIBA 01/2022 - 11/2015
8	Peptides (Polypeptides)IBA 01/2021 - 01/2017
8	Liposomes (Liposome)IBA 09/2018 - 10/2007
7	EnzymesIBA 04/2022 - 10/2015
7	CateninsIBA 01/2022 - 01/2018
7	Small Interfering RNA (siRNA)IBA 12/2021 - 02/2010
7	CholesterolIBA 01/2020 - 03/2005
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2010
6	GlucocorticoidsIBA 03/2022 - 05/2013
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2015
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
6	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2018
6	LipopolysaccharidesIBA 01/2022 - 09/2018
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2005
6	Sirolimus (Rapamycin)FDA Link 01/2021 - 12/2006
6	LigandsIBA 10/2020 - 02/2002
6	Therapeutic UsesIBA 09/2020 - 05/2009
5	AntioxidantsIBA 06/2022 - 11/2018
5	anlotinibIBA 01/2022 - 01/2021
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 12/2021 - 02/2005
5	AutoantibodiesIBA 12/2021 - 02/2002
5	ParaquatIBA 08/2021 - 04/2015
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2017
5	Indicators and Reagents (Reagents)IBA 01/2020 - 08/2017
5	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 02/2002
4	SmokeIBA 03/2022 - 06/2014

Therapy/Procedure

71	Therapeutics 06/2022 - 02/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 12/2004
10	Liver Transplantation 02/2022 - 01/2017
9	Immunotherapy 01/2022 - 09/2003
8	Ligation 11/2021 - 02/2012
6	Length of Stay 01/2022 - 06/2006
6	Radiotherapy 09/2020 - 12/2004
5	Punctures 04/2019 - 01/2015
4	Operative Time 07/2022 - 12/2010
4	Lasers (Laser) 04/2022 - 06/2016